Acyclovir Dosing for Herpes Zoster
For immunocompetent adults with herpes zoster, administer acyclovir 800 mg orally five times daily for 7-10 days, initiated within 72 hours of rash onset. 1
Dosing Regimen
The FDA-approved dosing for acute herpes zoster is 800 mg every 4 hours orally, 5 times daily for 7 to 10 days 1. This represents the standard of care and is supported by multiple clinical trials demonstrating superiority over lower doses.
Evidence Supporting This Dose
The 800 mg five times daily regimen has been extensively validated:
- Significantly superior to 400 mg five times daily in reducing viral shedding, accelerating time to 50% scabbing and healing, decreasing new lesion formation, and reducing acute pain severity (p=0.03 between days 3-10) 2
- Reduces time to last new lesion formation (p<0.01), loss of vesicles (p<0.01), and full crusting (p=0.03) compared to placebo 3
- Most effective when initiated within 48 hours of rash onset 3
A meta-analysis confirmed that 800 mg acyclovir five times daily shortens blister stopping time (MD=-1.29 days), pain duration (MD=-2.73 days), and scabbing time (MD=-2.42 days) compared to 200 mg dosing, without increasing adverse reactions 4.
Duration of Therapy
Standard duration is 7 days, though the FDA label allows for up to 10 days 1. A randomized trial found that extending treatment to 21 days conferred only slight additional benefits over 7-day therapy and did not reduce postherpetic neuralgia 5. Therefore, the standard 7-day course is appropriate for most patients.
Critical Timing
Treatment must be initiated within 72 hours of rash onset for optimal efficacy 1, 3. Patients starting therapy later than 48 hours after rash onset showed no significant hastening of rash healing 3.
Special Populations
Renal Impairment
Dosage adjustment is mandatory 1:
- CrCl >25 mL/min: 800 mg every 4 hours (5x daily)
- CrCl 10-25 mL/min: 800 mg every 8 hours
- CrCl 0-10 mL/min: 800 mg every 12 hours
- Hemodialysis: Administer additional dose after each dialysis session
Immunocompromised Patients
The provided guidelines address HIV-infected children specifically, recommending acyclovir 20 mg/kg orally (max 800 mg/dose) 4 times daily for 7-10 days or until no new lesions for 48 hours 6. For severe immunosuppression, IV therapy may be required.
Pediatric Patients
For children with zoster: 20 mg/kg body weight orally per dose (max 800 mg/dose) 4 times daily for 7-10 days 6.
Alternative Agents
While the question specifically asks about acyclovir, famciclovir (250 mg three times daily) and valacyclovir (900-1000 mg three times daily) are equally effective alternatives with more convenient dosing schedules 4, 7. However, acyclovir 800 mg five times daily remains the FDA-approved standard 1.
Common Pitfalls
- Inadequate hydration: Maintain adequate hydration to prevent renal dysfunction 1
- Late initiation: Therapy initiated >72 hours after rash onset has minimal benefit 3
- Underdosing: The 400 mg five times daily dose is ineffective; 800 mg is required 2
- Failure to adjust for renal function: This increases risk of neurotoxicity 1
- Expecting prevention of postherpetic neuralgia: Acyclovir reduces acute symptoms but does not consistently prevent postherpetic neuralgia 5, 3